Thursday, 17 August 2017

Generic Lidex Ointment by Lupin receives FDA approval

03 August 2017 | News

Lidex Ointment had US sales of USD 40.3 million

Source: Pixabay

Source: Pixabay

Pharma company Lupin Limited has announced that United States Food and Drug Administration (USFDA) has finally approved its Fluocinonide Topical Ointment USP, 0.05% to market a generic version of County Line Pharmaceuticals, LLC’s Lidex Ointment, 0.05%.

Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Lupin’s Fluocinonide Topical Ointment USP, 0.05% is AB rated generic equivalent of LLC’s Lidex Ointment, 0.05%.

Lidex Ointment had US sales of USD 40.3 million (IMS MAT March 2017).

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Are private sector's profits in healthcare soaring in India?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls